One governed operating layer for clinical trial execution.
Vivo brings together trial data, AI reasoning, continuous monitoring, evidence generation, and workflow action so teams can understand status, detect risk, and coordinate response across studies and portfolios.
From fragmented trial data to coordinated clinical action.
Clinical trials generate more data than ever, but most study teams still manage execution through disconnected systems, vendor portals, CRO reports, spreadsheets, and periodic status updates. That creates a gap between when data is collected and when teams can act on it. Vivo closes that gap.
Unified Clinical Trial Data Layer
Vivo ingests, harmonizes, and monitors structured and semi-structured trial data across systems. Every source remains traceable. Cross-domain review becomes possible across subjects, sites, visits, endpoints, labs, adverse events, vendors, and documents.
Supported source categories:
"A clinical trial is not one system. Vivo gives teams one operating picture."
API Integration
Real-time / near-real-time refresh where available (Medidata RAVE, PPD, Veeva Vault, etc.)
Batch / File Ingestion
Scheduled file processing: CSV, XML, SAS, CDISC ODM, JSON, flat files
Read-Only Source Integrity
Vivo never modifies source data. Source systems remain the system of record
AI-Assisted Data Unification
AI generates and validates data mapping code to accelerate onboarding
Trial Home
Trial Home gives study teams a continuously updated view of what is happening across the trial, what changed since the last review, what needs attention, and what actions are pending. Designed for the rhythm of real clinical development work.
Current status across enrollment, sites, vendors, data quality, safety, and protocol
What changed since the last review cycle
Emerging risks that require attention
Open alerts, issues, assignments, and review items
Trial News summaries for cross-functional teams
"Know what changed before the meeting starts."
Trial status: On track. 3 items need attention.
Site 104: Enrollment 40% behind plan — 18 days no screenings
Safety signal: AE cluster at Site 104 (Cohort B) — review recommended
CRO Vendor B: Lab data refresh overdue by 3 days
12 other items unchanged since last review
Ask Vivo — Governed Clinical Trial AI
Ask Vivo gives clinical development teams a governed AI interface to their own trial data, documents, protocol context, and operating workflows. Not a chatbot — a source-backed reasoning layer designed for clinical use.
Plain-language questions over live trial data and documents
Protocol and amendment question answering
Role-aware — every answer reflects your permissions
Source-backed explanations with evidence citations
Visual outputs, summaries, and generated tables
"Ask the trial. See the evidence."
Which subjects have missing data for critical endpoint visits in domains flagged for lock readiness?
14 subjects have incomplete data for ≥1 critical endpoint visit. 9 are in the primary endpoint domain (ADAS-Cog). Sites 211 and 308 account for 11 of the 14. 3 subjects have records that changed after their last review date.
Which studies have the highest execution risk this month across our oncology portfolio?
Study OS-204 has the highest composite risk: enrollment 18% behind plan, 2 site activations overdue, and 1 vendor data lag flag. Study OS-107 shows rising protocol deviation rate over 4 weeks (+22%).
Continuous Monitoring — AI-RBQM
A signal is only valuable if the right team sees it, understands it, and acts on it. Vivo continuously monitors trial data and turns signals into governed action.
Detect
Continuously watch for missing, late, inconsistent, unexpected, or high-risk patterns across all connected sources.
Alert
Generate governed alerts with source evidence and affected entities. Share across the team. Set thresholds from protocols or Ask Vivo prompts.
Act
Convert alerts to issues. Assign ownership. Track resolution. Preserve evidence packages for audit, inspection, and review.
Missing or delayed data
Cross-system discrepancies
Enrollment & screen failure trends
Site & vendor performance drift
Visit adherence & retention risk
Protocol deviations
Safety & medical review signals
Endpoint readiness
Lock-readiness blockers
Portfolio Intelligence
Vivo helps clinical development leaders move beyond study-by-study updates into portfolio-level intelligence. See where attention is needed, then drill into the study, site, subject, vendor, or data domain driving the issue.
Which studies carry the highest execution risk
Which sites or vendors are creating issues across programs
Which trials show worsening data quality trends
Which milestones are under pressure
What changed across the portfolio since the last review
"One study creates clarity. A portfolio creates operating leverage."Explore Vivo for Clinical Development Leadership →
Study OS-204 · Oncology Phase 2
Study CNS-107 · Alzheimer's Phase 2
Study IMM-033 · I&I Phase 3
Study RD-019 · Rare Disease Phase 2
Not a dashboard. Not a chatbot. Not another silo.
Dashboards show what happened.
Vivo explains what changed and what action should follow.
Chatbots answer questions.
Vivo monitors the trial and connects answers to source-backed workflows.
Data warehouses store data.
Vivo helps clinical teams interpret, prioritize, and act on data.
RBQM tools identify risk.
Vivo connects risk to evidence, issues, review workflows, and portfolio context.
"Our CMO went from spending a week plus manually collating and creating the various tables he wanted for DSMB to maybe 30, 45 minutes. That's just transformative to how we do business."
Bring trial data, AI reasoning, monitoring, and action into one governed layer.
Vivo helps clinical development teams understand what changed, detect risk earlier, ask better questions, and coordinate response with source-backed evidence.
